BIODESIX, INC. Operating Income
BIODESIX, INC. (BDSX) reported Operating Income of -$5.39 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2026-08-05
- BIODESIX, INC. operating income (loss) for the quarter ending 2026-06-30 was -$5.39M.
- BIODESIX, INC. operating income (loss) for the quarter ending 2026-03-31 was -$6.20M.
- BIODESIX, INC. operating income (loss) for the quarter ending 2025-12-31 was -$1.97M.
- BIODESIX, INC. operating income (loss) for the quarter ending 2025-09-30 was -$7.05M.
- BIODESIX, INC. operating income (loss) for fiscal 2025 was -$27.87M.
- BIODESIX, INC. operating income (loss) for fiscal 2024 was -$34.50M.
- BIODESIX, INC. operating income (loss) for fiscal 2023 was -$41.34M.
- BIODESIX, INC. operating income (loss) for fiscal 2022 was -$50.59M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 6 month | Operating Income (Loss) 9 month | Operating Income (Loss) 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$5.39M 10-Q · filed 2026-08-05 | -$11.59M 10-Q · filed 2026-08-05 | -$13.56M derived: sum of 3 quarters · filed 2026-08-05 | -$20.61M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | -$6.20M 10-Q · filed 2026-05-04 | -$8.17M derived: sum of 2 quarters · filed 2026-05-04 | -$15.22M derived: sum of 3 quarters · filed 2026-05-04 | -$24.94M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | -$1.97M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$9.02M derived: sum of 2 quarters · filed 2026-02-26 | -$18.74M derived: sum of 3 quarters · filed 2026-08-05 | -$27.87M 10-K · filed 2026-02-26 |
| 2025-09-30 | -$7.05M 10-Q · filed 2025-11-03 | -$16.77M derived: sum of 2 quarters · filed 2026-08-05 | -$25.91M 10-Q · filed 2025-11-03 | -$32.55M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | -$9.72M 10-Q · filed 2026-08-05 | -$18.86M 10-Q · filed 2026-08-05 | -$25.50M derived: sum of 3 quarters · filed 2026-08-05 | -$34.09M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | -$9.14M 10-Q · filed 2026-05-04 | -$15.79M derived: sum of 2 quarters · filed 2026-05-04 | -$24.38M derived: sum of 3 quarters · filed 2026-05-04 | -$32.61M derived: sum of 4 quarters · filed 2026-05-04 |
| 2024-12-31 | -$6.65M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$15.24M derived: sum of 2 quarters · filed 2026-02-26 | -$23.48M derived: sum of 3 quarters · filed 2026-02-26 | -$34.50M 10-K · filed 2026-02-26 |
| 2024-09-30 | -$8.59M 10-Q · filed 2025-11-03 | -$16.83M derived: sum of 2 quarters · filed 2025-11-03 | -$27.85M 10-Q · filed 2025-11-03 | -$34.72M derived: sum of 4 quarters · filed 2025-11-03 |
| 2024-06-30 | -$8.24M 10-Q · filed 2025-08-07 | -$19.26M 10-Q · filed 2025-08-07 | -$26.13M derived: sum of 3 quarters · filed 2025-08-07 | -$33.30M derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | -$11.02M 10-Q · filed 2025-05-13 | -$17.89M derived: sum of 2 quarters · filed 2025-05-13 | -$25.06M derived: sum of 3 quarters · filed 2025-05-13 | -$35.99M derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | -$6.87M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | -$14.04M derived: sum of 2 quarters · filed 2025-03-03 | -$24.97M derived: sum of 3 quarters · filed 2025-03-03 | -$41.34M 10-K · filed 2025-03-03 |
| 2023-09-30 | -$7.17M 10-Q · filed 2024-11-01 | -$18.10M derived: sum of 2 quarters · filed 2024-11-01 | -$34.47M 10-Q · filed 2024-11-01 | -$48.36M derived: sum of 4 quarters · filed 2024-11-01 |
| 2023-06-30 | -$10.93M 10-Q · filed 2024-08-07 | -$27.30M 10-Q · filed 2024-08-07 | -$41.19M derived: sum of 3 quarters · filed 2024-08-07 | -$51.80M derived: sum of 4 quarters · filed 2024-08-07 |
| 2023-03-31 | -$16.37M 10-Q · filed 2024-05-08 | -$30.26M derived: sum of 2 quarters · filed 2024-05-08 | -$40.87M derived: sum of 3 quarters · filed 2024-05-08 | -$52.50M derived: sum of 4 quarters · filed 2024-05-08 |
| 2022-12-31 | -$13.89M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-01 | -$24.50M derived: sum of 2 quarters · filed 2024-03-01 | -$36.13M derived: sum of 3 quarters · filed 2024-03-01 | -$50.59M 10-K · filed 2024-03-01 |
| 2022-09-30 | -$10.61M 10-Q · filed 2023-11-07 | -$22.24M derived: sum of 2 quarters · filed 2023-11-07 | -$36.70M 10-Q · filed 2023-11-07 | -$48.38M derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | -$11.63M 10-Q · filed 2023-08-07 | -$26.09M 10-Q · filed 2023-08-07 | -$37.77M derived: sum of 3 quarters · filed 2023-08-07 | -$50.86M derived: sum of 4 quarters · filed 2023-08-07 |
| 2022-03-31 | -$14.46M 10-Q · filed 2023-05-11 | -$26.14M derived: sum of 2 quarters · filed 2023-05-11 | -$39.23M derived: sum of 3 quarters · filed 2023-05-11 | -$49.82M derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | -$11.68M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | -$24.77M derived: sum of 2 quarters · filed 2023-03-06 | -$35.36M derived: sum of 3 quarters · filed 2023-03-06 | -$40.94M 10-K · filed 2023-03-06 |
| 2021-09-30 | -$13.09M 10-Q · filed 2022-11-03 | -$23.68M derived: sum of 2 quarters · filed 2022-11-03 | -$29.26M 10-Q · filed 2022-11-03 | -$31.91M derived: sum of 4 quarters · filed 2022-11-03 |
| 2021-06-30 | -$10.59M 10-Q · filed 2022-08-04 | -$16.17M 10-Q · filed 2022-08-04 | -$18.82M derived: sum of 3 quarters · filed 2022-08-04 | -$25.06M derived: sum of 4 quarters · filed 2022-08-04 |
| 2021-03-31 | -$5.58M 10-Q · filed 2022-05-11 | -$8.24M derived: sum of 2 quarters · filed 2022-05-11 | -$14.48M derived: sum of 3 quarters · filed 2022-05-11 | -$20.09M derived: sum of 4 quarters · filed 2022-05-11 |
| 2020-12-31 | -$2.65M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-14 | -$8.89M derived: sum of 2 quarters · filed 2022-03-14 | -$14.51M derived: sum of 3 quarters · filed 2022-03-14 | -$22.93M 10-K · filed 2022-03-14 |
| 2020-09-30 | -$6.24M 10-Q · filed 2021-11-15 | -$11.86M derived: sum of 2 quarters · filed 2021-11-15 | -$20.28M 10-Q · filed 2021-11-15 | -$23.82M derived: sum of 4 quarters · filed 2021-11-15 |
| 2020-06-30 | -$5.62M 10-Q · filed 2021-08-10 | -$14.04M 10-Q · filed 2021-08-10 | -$17.59M derived: sum of 3 quarters · filed 2021-08-10 | -$26.61M derived: sum of 4 quarters · filed 2021-08-10 |
| 2020-03-31 | -$8.42M 10-Q · filed 2021-05-11 | -$11.97M derived: sum of 2 quarters · filed 2021-05-11 | -$20.99M derived: sum of 3 quarters · filed 2021-05-11 | |
| 2019-12-31 | -$3.54M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16 | -$12.57M derived: sum of 2 quarters · filed 2021-03-16 | -$26.74M 10-K · filed 2021-03-16 | |
| 2019-09-30 | -$9.03M 10-Q · filed 2020-12-10 | -$23.20M 10-Q · filed 2020-12-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |